Browse by People

Collapse authors list.
Kudo, Masatoshi, Galle, Peter R, Brandi, Giovanni, Kang, Yoon-Koo, Yen, Chia-Jui, Finn, Richard S, Llovet, Josep M, Assenat, Eric, Merle, Philippe, Chan, Stephen L et al (show 11 more authors) , Palmer, Daniel H ORCID: 0000-0002-7147-5703, Ikeda, Masafumi, Yamashita, Tatsuya, Vogel, Arndt, Huang, Yi-Hsiang, Abada, Paolo B, Yoshikawa, Reigetsu, Shinozaki, Kenta, Wang, Chunxiao, Widau, Ryan C and Zhu, Andrew X (2021) Effect of ramucirumab on ALBI grade in patients with advanced HCC: Results from REACH and REACH-2. JHEP REPORTS, 3 (2). 100215-.

Collapse authors list.
Verset, Gontran, Borbath, Ivan, Karwal, Mark, Verslype, Chris, Van Vlierberghe, Hans, Kardosh, Adel, Zagonel, Vittorina, Stal, Per, Sarker, Debashis, Palmer, Daniel H ORCID: 0000-0002-7147-5703 et al (show 16 more authors) , Vogel, Arndt, Edeline, Julien, Cattan, Stephane, Kudo, Masatoshi, Cheng, Ann-Lii, Ogasawara, Sadahisa, Daniele, Bruno, Chan, Stephen L, Knox, Jennifer J, Qin, Shukui, Siegel, Abby B, Chisamore, Michael, Hatogai, Ken, Wang, Anran, Finn, Richard S and Zhu, Andrew X (2022) Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial. CLINICAL CANCER RESEARCH, 28 (12). pp. 2547-2554.

Collapse authors list.
Kudo, Masatoshi, Finn, Richard S, Edeline, Julien, Cattan, Stephane, Ogasawara, Sadahisa, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Verslype, Chris, Zagonel, Vittorina, Fartoux, Laetitia, Vogel, Arndt et al (show 11 more authors) , Sarker, Debashis, Verset, Gontran, Chan, Stephen L, Knox, Jennifer, Daniele, Bruno, Yau, Thomas, Gurary, Ellen B, Siegel, Abby B, Wang, Anran, Cheng, Ann-Lii and Zhu, Andrew X (2022) Updated efficacy and safety of KEYNOTE-224: a phase II study of pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib. EUROPEAN JOURNAL OF CANCER, 167. pp. 1-12.